Tapewire

Nasdaq · USD

SILO

Silo Pharma, Inc.

Export transactions ↓
Tapewire entity
8320
SEC CIK
0001514183
Parsed reports
37

Last 12 months

Inside the activity.

6 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202540
Dec 202520
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 28, 2020 Filed May 17, 2021 11:33 UTC Amendment
Weisblum EricDirector · CEO, CFO and President
GrantCommon Stock 7,630,949 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-21-026677 · ownership.xml · nonDerivative · entry 1

Weisblum Eric · CIK 0001569077 · Director · CEO, CFO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,689,063

F1 · price: Issued to the Reporting Person pursuant to that certain Employment Agreement, dated April 17, 2020, by and between the Issuer and the Reporting Person.

F2 · balance_after: This Form 4 is being filed to amend the prior Form 4 filed by the Reporting Person on April 30, 2020, which erroneously included the Reporting Person's stock options in Column 5 of Table I.

Read SEC document
April 17, 2020 Filed May 1, 2020 00:42 UTC
Weisblum EricDirector · CHIEF EXECUTIVE OFFICER
GrantCommon Stock 7,630,949 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-20-010688 · ownership.xml · nonDerivative · entry 1

Weisblum Eric · CIK 0001569077 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,988,663

F1 · price: Issued to Reporting Person pursuant to that certain Employment Agreement, dated April 17, 2020, between the Issuer and Reporting Person.

Read SEC document
October 22, 2019 Filed May 17, 2021 11:31 UTC
Weisblum EricDirector · CEO, CFO and President
PurchaseCommon Stock 200 $0.45 $90.00
Disclosure

SEC source: 0001213900-21-026675 · ownership.xml · nonDerivative · entry 3

Weisblum Eric · CIK 0001569077 · Director · CEO, CFO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,114

Read SEC document
October 15, 2019 Filed May 17, 2021 11:31 UTC
Weisblum EricDirector · CEO, CFO and President
GrantStock Option (right to buy) · Derivative 100,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001213900-21-026675 · ownership.xml · derivative · entry 6

Weisblum Eric · CIK 0001569077 · Director · CEO, CFO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2024-10-15

Read SEC document
October 15, 2019 Filed May 17, 2021 11:31 UTC
Weisblum EricDirector · CEO, CFO and President
PurchaseCommon Stock 200 $0.38 $76.00
Disclosure

SEC source: 0001213900-21-026675 · ownership.xml · nonDerivative · entry 2

Weisblum Eric · CIK 0001569077 · Director · CEO, CFO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,914

Read SEC document
June 17, 2019 Filed May 17, 2021 11:31 UTC
Weisblum EricDirector · CEO, CFO and President
PurchaseCommon Stock 57,714 $0.00 $115.43
Disclosure

SEC source: 0001213900-21-026675 · ownership.xml · nonDerivative · entry 1

Weisblum Eric · CIK 0001569077 · Director · CEO, CFO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,714

Read SEC document
April 15, 2019 Filed May 17, 2021 11:31 UTC
Weisblum EricDirector · CEO, CFO and President
GrantStock Option (right to buy) · Derivative 100,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001213900-21-026675 · ownership.xml · derivative · entry 5

Weisblum Eric · CIK 0001569077 · Director · CEO, CFO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2024-07-15

F2 · date: The options were granted on April 15, 2019 and vested in full on July 15, 2019.

F1 · price: The options were granted pursuant to the Employment Agreement by and between the Issuer and the Reporting Person dated April 15, 2019.

F2 · derivative.exercise_date: The options were granted on April 15, 2019 and vested in full on July 15, 2019.

Read SEC document
April 15, 2019 Filed May 17, 2021 11:31 UTC
Weisblum EricDirector · CEO, CFO and President
GrantStock Option (right to buy) · Derivative 100,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001213900-21-026675 · ownership.xml · derivative · entry 4

Weisblum Eric · CIK 0001569077 · Director · CEO, CFO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2024-04-15

F1 · price: The options were granted pursuant to the Employment Agreement by and between the Issuer and the Reporting Person dated April 15, 2019.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.